Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine - Business Wire Get link Facebook X Pinterest Email Other Apps October 30, 2019 Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine Business Wire Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment